GeNeuro
Switzerland - GenevaBiotechnology
Focus: GeNeuro is a Swiss biotech focused on CNS drugs, particularly neurology indications like multiple sclerosis. The company operates as a clinical-stage developer with a narrow therapeutic focus.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About GeNeuro
AI assessmentNot HiringNo open roles listed right now. Follow GeNeuro to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
12 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
No study treatments administered
Multiple SclerosisClinical Trials (1)
NCT01804660Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Normal Population
N/AHelp build intelligence for GeNeuro
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.